NSDHL Antibodies

Santa Cruz Biotechnology features a diverse variety of NSDHL Antibodies for research focused on understanding NSDHL protein function. NSDHL Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).NSDHL, or NAD(P)H steroid dehydrogenase-like protein, plays a critical role in the cholesterol biosynthetic pathway and is essential for the synthesis of sterols and isoprenoids. NSDHL is involved in the regulation of cellular processes, including membrane fluidity and signaling pathways, making it vital for maintaining cellular homeostasis. Dysregulation of NSDHL has been implicated in various metabolic disorders, highlighting its significance in both basic and clinical research. NSDHL research has revealed important connections to developmental processes and cellular metabolism. Understanding NSDHL function continues to provide new perspectives on metabolic regulation and disease mechanisms. Recent studies have demonstrated NSDHL's influence on cell growth and differentiation pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific knowledge of NSDHL's role in human health and disease progression.